Alternative therapies for metastatic breast cancer: multimodal approach targeting tumor cell heterogeneity

Breast Cancer Targets and Therapy ◽

10.2147/bctt.s130838 ◽

2017 ◽

Vol Volume 9 ◽

pp. 85-93 ◽

Cited By ~ 7

Author(s):

Manpreet Sambi ◽

Sabah Haq ◽

Vanessa Samuel ◽

Bessi Qorri ◽

Fiona Haxho ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Tumor Cell ◽

Metastatic Breast ◽

Alternative Therapies ◽

Multimodal Approach ◽

Cell Heterogeneity ◽

Tumor Cell Heterogeneity

Download Full-text

Faculty Opinions recommendation of Mutation Analysis of Cell-Free DNA and Single Circulating Tumor Cells in Metastatic Breast Cancer Patients with High Circulating Tumor Cell Counts.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726443839.793535260 ◽

2017 ◽

Cited By ~ 1

Author(s):

Wafik El-Deiry

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Tumor Cell ◽

Cancer Patients ◽

Tumor Cells ◽

Metastatic Breast ◽

Circulating Tumor Cell ◽

Breast Cancer Patients ◽

Cell Counts ◽

Free Dna

Download Full-text

Abstract GS4-08: Clinical utility of repeated circulating tumor cell (CTC) enumeration as early treatment monitoring tool in metastatic breast cancer (MBC) - a global pooled analysis with individual patient data

10.1158/1538-7445.sabcs20-gs4-08 ◽

2021 ◽

Author(s):

Wolfgang J Janni ◽

Tracy C. Yab ◽

Daniel F. Hayes ◽

Massimo Cristofanilli ◽

Francois-Clement Bidard ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Tumor Cell ◽

Clinical Utility ◽

Individual Patient Data ◽

Metastatic Breast ◽

Circulating Tumor Cell ◽

Pooled Analysis ◽

Treatment Monitoring ◽

Monitoring Tool

Download Full-text

Rho-kinase (ROK) promotes CD44v3,8-10-ankyrin interaction and tumor cell migration in metastatic breast cancer cells

Cell Motility and the Cytoskeleton ◽

10.1002/(sici)1097-0169(1999)43:4<269::aid-cm1>3.0.co;2-5 ◽

1999 ◽

Vol 43 (4) ◽

pp. 269-287 ◽

Cited By ~ 90

Author(s):

Lilly Y.W. Bourguignon ◽

Hongbo Zhu ◽

Lijun Shao ◽

Dan Zhu ◽

You-Wei Chen

Keyword(s):

Breast Cancer ◽

Cell Migration ◽

Metastatic Breast Cancer ◽

Tumor Cell ◽

Cancer Cells ◽

Breast Cancer Cells ◽

Rho Kinase ◽

Metastatic Breast ◽

Tumor Cell Migration

Download Full-text

Abstract P132: Promotion of E-cadherin-mediated tumor cell adhesion by COX-2/GSK3b signaling is a targetable mechanism of metastatic breast cancer

10.1158/1535-7163.targ-21-p132 ◽

2021 ◽

Author(s):

Balamurugan Kuppusamy ◽

Saadiya Sehareen ◽

Savitri Krishnamurthy ◽

Shikha Sharana ◽

Wei Tang ◽

...

Keyword(s):

Breast Cancer ◽

Cell Adhesion ◽

Metastatic Breast Cancer ◽

Tumor Cell ◽

Metastatic Breast ◽

Tumor Cell Adhesion ◽

Cox 2 ◽

E Cadherin

Download Full-text

Abstract S5-07: SWOG S0500 – A randomized phase III trial to test the strategy of changing therapy versus maintaining therapy for metastatic breast cancer patients who have elevated circulating tumor cell (CTC) levels at first follow-up assessment

10.1158/0008-5472.sabcs13-s5-07 ◽

2013 ◽

Cited By ~ 5

Author(s):

JB Smerage ◽

WE Barlow ◽

DF Hayes ◽

EP Winer ◽

B Leyland-Jones ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Tumor Cell ◽

Cancer Patients ◽

Metastatic Breast ◽

Circulating Tumor Cell ◽

Phase Iii ◽

Breast Cancer Patients ◽

Phase Iii Trial

Download Full-text

Abstract 1351: A novel application of DEPArrayTMNxT System to isolate circulating tumor cell (CTC)-clusters from patients with metastatic breast cancer (MBC)

10.1158/1538-7445.am2019-1351 ◽

2019 ◽

Author(s):

Qiang Zhang ◽

Lorenzo Gerratana ◽

Ami N. Shah ◽

Andrew A. Davis ◽

Lisa Flaum ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Tumor Cell ◽

Metastatic Breast ◽

Circulating Tumor Cell

Download Full-text

Abstract 3119: Comparison of circulating tumor cell (CTC) derived DNA and circulating cell-free DNA (cfDNA) from simultaneous blood sampling of patients with metastatic breast cancer (MBC)

10.1158/1538-7445.am2020-3119 ◽

2020 ◽

Author(s):

Minetta C. Liu ◽

Karthik V. Giridhar ◽

Roberto A. Leon Ferre ◽

Jamie L. Carroll ◽

Matthew P. Goetz ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Tumor Cell ◽

Metastatic Breast ◽

Circulating Tumor Cell ◽

Blood Sampling ◽

Cell Free Dna ◽

Free Dna ◽

Circulating Cell Free Dna

Download Full-text

Abstract P6-09-01: In primary, non-metastatic breast cancer patients, increased serum levels of RANKL significantly correlate with tumor cell spread to the bone and the occurrence of bone metastasis whereas high levels of its soluble decoy receptor osteoprotegerin predict poor survival

10.1158/1538-7445.sabcs18-p6-09-01 ◽

2019 ◽

Author(s):

A-K Bittner ◽

A Goebel ◽

O Hoffmann ◽

M Rauner ◽

LC Hofbauer ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Bone Metastasis ◽

Tumor Cell ◽

Metastatic Breast ◽

Serum Levels ◽

Breast Cancer Patients ◽

Poor Survival ◽

Decoy Receptor ◽

Cell Spread

Download Full-text

Abstract P3-01-10: Associations between plasma Interleukin 2 (IL-2) and HER2 expression in circulating tumor cell (CTC) and MYC alterations in circulation tumor DNA (ctDNA) open a new insight on immune microenvironment for patients with metastatic breast cancer (MBC)

10.1158/1538-7445.sabcs18-p3-01-10 ◽

2019 ◽

Author(s):

Q Zhang ◽

L Gerratana ◽

Y Zhang ◽

L Flaum ◽

A Shah ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Tumor Cell ◽

Interleukin 2 ◽

Metastatic Breast ◽

Circulating Tumor Cell ◽

Her2 Expression ◽

Immune Microenvironment ◽

Tumor Dna

Download Full-text

Abstract P3-01-05: Circulating tumor cell detection predicts early recurrence in patients with non-metastatic breast cancer

10.1158/1538-7445.sabcs18-p3-01-05 ◽

2019 ◽

Author(s):

C Hall ◽

S Meas ◽

J Bowman Bauldry ◽

H Kuerer ◽

A Lucci

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Tumor Cell ◽

Metastatic Breast ◽

Circulating Tumor Cell ◽

Early Recurrence ◽

Cell Detection ◽

Tumor Cell Detection

Download Full-text